Tag: bioequivalence

Learn how IVIVC models allow pharma companies to replace costly human trials with lab-based dissolution testing, securing regulatory biowaivers for generic drugs.

Explore the real difference between generic and brand-name drugs. Learn about bioequivalence, FDA standards, and when a generic switch might actually matter for your health.

Partial AUC (pAUC) is a sophisticated pharmacokinetic tool used by the FDA and EMA to ensure generic drugs match brand-name versions in early drug release-critical for safety and efficacy. Learn how it works, why it's replacing old metrics, and what it means for generic drug development.

Dissolution profile comparison is the key method regulators use to prove generic drugs work like brand-name versions. Learn how f2 scores, lab standards, and advanced stats ensure generics are safe and effective.

Modified-release formulations require special bioequivalence testing to ensure generic versions release drugs at the same rate and time as brand-name drugs. Learn the key regulatory requirements, testing methods, and common failure points.

Switching between different generic medications can be safe - or risky, depending on the drug. Learn which generics are interchangeable, which ones need caution, and how to protect yourself from dangerous changes.